Valneva and IDT Biologika end COVID-19 manufacturing contract
Valneva and IDT Biologika have agreed to terminate their COVID-19 vaccine collaboration in light of reduced orders for the vaccine.
Archives for September 21, 2022
Building up Australia’s vaccine manufacturing capacity
Almost all of Australia’s vaccines are imported: creating a potential crisis in a pandemic. As a result, the country is setting out its strategy for developing vaccine manufacturing capabilities.
Germany’s ProBioGen supporting City of Hope’s CMV vaccine program
The two entities have signed a non-exclusive licensing agreement.
Patch vaccine innovator Vaxxas receives $8.2m grant to scale-up manufacturing facility
Vaxxas will receive an AU$8.2m second round grant to support the manufacturing scale-up of its technology that enables vaccines to be applied to the skin using a small patch.